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We measured markers of eosinophilic inflammation in the blood and in the sputum induced by hypertonic saline 
(HS) inhalation of 24 subjects with occupational asthma who were still exposed to high molecular weight compounds 
(HMWCs, n=8) or to low molecular weight compounds (LMWCs, n=16); all subjects were symptomatic and 
showed bronchial hyperresponsiveness to methacholine at the time of study. Sputum cell counts were also measured 
in 14 normal subjects and in 24 subjects with non-occupational asthma with asthma severity similar to that of 
occupational asthmatics. 
Both occupational and non-occupational asthmatic subjects showed higher neutrophil percentages in HS-induced 
sputum than normal subjects, asthmatics with LMWC-induced asthma showing the highest values. Eosinophil 
percentages in HS-induced sputum were higher in non-occupational asthmatics and in asthmatics with HMWC- 
induced asthma than in normal subjects and in subjects with occupational asthma due to LMWCs. No difference in 
bronchial responsiveness, peak expiratory flow variability and serum eosinophil cationic protein (ECP) levels were 
observed among the different asthma groups. Although sputum eosinophil percentages significantly correlated with 
blood eosinophil percentages, sputum allowed the detection of a higher number of subjects with eosinophilic 
inflammation than blood. Serum ECP levels were normal in most asthmatic subjects. A significant correlation 
between sputum eosinophil percentages and bronchial hyperresponsiveness to HS was observed. 
Despite a similar degree of functional abnormalities, subjects with asthma due to LMWCs and still exposed to the 
occupational sensitizer showed a lower degree of eosinophilic inflammation and a higher degree of neutrophilic 
inflammation in the airways than subjects with occupational asthma due to HMWCs or non-occupational 
asthmatics. Furthermore, sputum eosinophil counts detect, better than blood indices, the degree of airway 
inflammation in both occupational and non-occupational asthma. 
RESPIR. MED. (1998) 92, 550-557 
Introduction 
Airway inflammation is a major factor in the patho- 
physiology of asthma (1). The cellular and molecular 
markers of this inflammation appear to correlate with the 
severity of asthma (2) and with its outcome according to the 
exposure to a specific sensitizer (3) and to pharmacological 
treatment (4). Until recently, the analysis of cells and 
mediators in the airway lining fluid and the bronchial 
mucosa from stable asthmatic subjects has been performed 
by means of bronchial lavage (BL) and biopsy (5,6), but 
discomfort, inconvenience and risks limit their applicability 
(7). Examination of sputum is a less invasive procedure (8), 
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but most asthmatic subjects do not produce sputum 
spontaneously. The analysis of sputum induced by 
inhalation of hypertonic saline (HS) solution has shown 
that induced sputum from asthmatic subjects, as well as 
spontaneous sputum, contains a significantly higher 
proportion of eosinophils and metachromatic cells than 
sputum from healthy subjects and from smokers with 
chronic non-obstructive bronchitis (9,lO). Recent studies 
have shown that induced sputum analysis is a reproducible 
and reliable method to assess airway inflammation (11,12) 
and to evaluate asthma outcome (13,14). 
Some studies have investigated airway inflammation in 
subjects with occupational asthma. Bronchial biopsy and 
lavage have been performed in small groups of subjects 
with occupational asthma still at work or after removal 
from exposure to the offending agent (3,15-l@ or during 
specific bronchial provocative test (19,20). Although the 
pathology of occupational asthma is similar to that of 
non-occupational asthma (21), the pathogenic mechanisms 
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TABLE 1. Clinical findings of normal subjects and subjects with occupational or non-occupational 
asthma (subjects with occupational asthma are divided according to the type of sensitizing agent) 
Occupational asthma 
Non-occupational 
LMWC HMWC asthma Normal 
Number of subjects 16 8 24 14 
Age (years), mean (range) 46 (22-64)* 44 (28-58) 34 (17-65) 34 (2244) 
Sex (M:F) 10:6 8:O 10:6 8:6 
Smoke (yes:no:ex) 0:8:8 0:3:5 2:13:9 3:ll:O 
AtOm 3 3 17 2 
Asthma duration (yr), mean (range) 6 (1-17) 10 (l-23) 10 (l-25) - 
Previous ICS treatment 7 1 0 
Asthma severity (MI:MP:MoP) 7:3:6 3:3:2 9:5:10 
M, male; F, female; MI, mild intermittent; MP, mild persistent; MOP, moderate persistent; ICS, 
inhaled corticosteroids. 
*P<O.O5 vs. normal. 
of occupational asthma may be heterogeneous depending 
on the chemical property of the specific sensitizer (allergens 
vs. simple chemicals). In particular, it is not completely 
understood whether the type and the severity of air- 
way inflammation in subjects with occupational asthma 
are related to different pathogenic mechanisms (IgE- vs. 
non-IgE-mediated asthma) and whether it differs from 
non-occupational asthma. 
The aim of this study was to measure markers of airway 
inflammation in induced sputum and in the blood from 
subjects with occupational asthma due to different sensi- 
tizers and to compare the results with the same markers 
obtained from normal subjects and from subjects with 
non-occupational asthma. 
Subjects and Methods 
SUBJECTS 
We studied 24 subjects with occupational asthma induced 
by low molecular weight compounds [LMWCs: TDI, in 14 
subjects, and methylene diphenyl-diisocyanate (MDI) in 
two subjects] and by high molecular weight compounds 
(HMWCs: flour in five subjects, tobacco or wood dust in 
three subjects) who were observed consecutively in our unit 
during a 2 yr period. All subjects were currently exposed to 
the sensitizing agent. The diagnosis had been previously 
confirmed by a positive bronchial challenge test with the 
appropriate sensitizing agent. At the time of the present 
study, all subjects were symptomatic and showed bronchial 
hyperresponsiveness to methacholine. The median duration 
of work exposure was 17 yr (range: 245 yr) and the median 
duration of illness was 5 yr (range: l-23 yr). Thirteen 
patients were ex-smokers; they stopped smoking 2-20 yr 
before the beginning of the study. Six subjects were atopic 
as assessed by multiple skin prick tests to a panel of 
common allergens. All subjects had monitored the peak 
expiratory flow (PEF) for two working weeks before the 
study. Eight patients with occupational asthma were in 
treatment with regular inhaled beclomethasone dipro- 
pionate, 500-1OOOpg daily (duration of previous treatment: 
l-5 yr); however, all subjects withdrew pharmacological 
treatment in the last month, except inhaled &agonists as 
needed. 
For comparison, 24 non-occupational naive asthmatics 
(17 atopic and seven non-atopic subjects) with asthma 
severity of similar degree underwent the same protocol, and 
14 normal subjects underwent sputum induction and 
analysis. There were two current smokers and nine 
ex-smokers (smoking cessation: 2-10 yr) in the non- 
occupational asthmatic group and three current smokers in 
the control group. 
All subjects had been free of respiratory infections for at 
least 4 weeks. In each subject, asthma severity was assessed 
by frequency of symptoms and rescue medication, FEV, 
value and PEF variability, according to the international 
guidelines (1). The main clinical findings of normal and 
asthmatic subjects are reported in Table 1. 
STUDY PROTOCOL 
All subjects attended to our laboratory on two different 
days separated at most by 1 week. On day 1, they under- 
went spirometry and methacholine challenge tests. On day 
2, a venous blood sample for eosinophil counts and serum 
eosinophil cationic protein (ECP) measurement was col- 
lected; then the subjects underwent sputum induction with 
HS. 
The study had been approved by the local Ethics 
Committee of the University and informed consent was 
given by all subjects. 
METHACHOLINE CHALLENGE TEST 
Methacholine (Sigma, St. Louis, MO, U.S.A.) was 
delivered by a DeVilbiss 646 jet nebulizer using a procedure 
described elsewhere (22). Briefly, phosphate-buffered saline 
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was inhaled first, followed every 2 min by methacholine 
inhalation from 0.04 to 3.2 mg of cumulative doses of 
methacholine in different steps. FEV, was measured 2 min 
after each step. The test was stopped when FEV, fell by 
20% or more below the post-diluent value, and PD,, FEV, 
(the cumulative dose producing 20% fall in FEV,) was 
computed. A PD,, FEV, value lower than 1 mg of 
methacholine was considered as positive for bronchial 
hyperresponsiveness. 
PEAK EXPIRATORY FLOW MONITORING 
All subjects were asked to monitor PEF by means of a Mini 
Wright peak flow meter four times daily for 14 consecutive 
days. Occupational asthmatics monitored PEF during two 
working weeks. On each occasion, the subjects performed 
three blows and recorded the highest value on a diary card. 
Subjects were also instructed to measure PEF each time 
they had dyspnoea or wheeze, before and 10 min after the 
use of rescue b,-agonist. For each subject the mean of daily 
maximal amplitudes (MA, maximum value minus mini- 
mum value during the day, as a percentage of mean daily 
value) and the percentage of days with daily MA> 10% were 
computed for the 14 days of monitoring (23). 
SERUM ECP 
Whole blood (6 ml) was allowed to clot for 50-70 min at 
room temperature (20-22°C) and centrifuged at 15OOg for 
10 min, and the supernatant was again centrifuged to 
ensure complete cell removal. Serum samples were stored at 
- 80°C until the assay. 
ECP was measured by specific radioimmunological 
method (ECP RIA Pharmacia, Uppsala, Sweden); this 
method has been proven as highly specific and sensitive 
(detection limit: 2,ug l- ‘) with high intra- and interassay 
reproducibility. The upper limit of the normal range is 
16pg l- ’ (24). 
SPUTUM INDUCTION 
Sputum was induced according to the method of Pin et al. 
(lo), slightly modified (25). No &agonist was administered 
as a pre-treatment, in order to evaluate also the airway 
response to the hypertonic stimulus. The HS was nebulized 
with an ultrasonic nebulizer (Sirius, Technomed, Firenze, 
Italy) with a 2.8 ml min ~ ’ output, and was inhaled for 
5 min periods for up to 30 min. NaCl solution was 
increased at intervals of 10 min from 3% to 4% to 5%. FEV, 
and FVC values were measured before the inhalation test 
and every 5 min during HS inhalation. At 10 min after the 
start of nebulization and every 5 min thereafter subjects 
were asked to rinse their mouth and were encouraged to 
cough sputum into a clean container. To help control for 
salivary contamination of induced sputum, samples of 
saliva and sputum were collected separately and saliva was 
discharged The nebulization was stopped after 30 min or 
when FEV, fell by 20% or more from baseline. Airway 
response to HS was expressed as total duration (minutes) of 
HS inhalation and as maximum FEV, (%) fall from 
baseline value. 
SPUTUM PROCESSING 
The entire collected sputum sample was used for analysis. 
Sputum samples were diluted with an equal volume of 
0.1% dithiotreithol (Sputasol; Unipath Ltd, Basingstoke, 
U.K.). Samples were incubated in a shaking bath at 37°C 
for 20 min, then pipetted to dissolve mucus plugs further. 
An aliquot (150 ~1) of sputum sample was cytocentrifuged 
(Cytospin; Shandon Scientific, Sewickley, PA, U.S.A.) and 
stained with Diff-Quik (Baxter Scientific Products, Miami, 
FL, U.S.A.). Two investigators, blinded to the subject’s 
history, each first counted at least 500 cells on the slides 
(usually two or three slides) of each sputum sample to 
obtain the squamous cell percentage as an indicator of 
saliva contamination. Cytospin slides with an amount of 
squamous cells such that 500 non-squamous cells could not 
be counted were considered unsatisfactory and discarded. 
Thus, at least 500 non-squamous cells were counted on 
satisfactory slides. All cell percentages were averaged 
to give the final values reported here. Macrophage, 
lymphocyte, neutrophil, and eosinophil percentages were 
thus expressed as percentages of total inflammatory cells, 
excluding squamous cells. 
The remainder of the sputum sample was centrifuged at 
450 g for 10 min. The cell pellets were resuspended in 
normal saline for total cell counts with the Turk method in 
a haemocytometer. Total inflammatory cell counts in the 
whole sputum sample were derived taking into account the 
percentage of squamous cells and expressed as number of 
cells per unit of sputum volume. 
In our laboratory, the reproducibility of differential cell 
percentages obtained with this method has been evaluated 
in 20 stable mild to moderate asthmatic patients in whom 
sputum was induced by HS inhalation on two different days 
separated by 1 week. Preliminary results show intraclass 
correlation coefficients (RI) (26) of +0.90 for macrophages, 
+0.88 for neutrophils, +0.23 for lymphocytes and +0.82 
for eosinophils (27). 
STATISTICAL ANALYSIS 
Cell percentages in blood and in induced sputum, as well as 
serum ECP levels and PD,, FEV, methacholine, were 
expressed as median (range). Baseline FEV, (percentage of 
predicted value), maximum percentage FEV, fall after HS 
inhalation and duration of HS inhalation were expressed as 
mean f SD. 
Analysis of variance was used to compare maximum 
percentage FEV, fall and duration of hypertonic saline 
inhalation and total sputum cell counts among groups. The 
Kruskal-Wallis test was used to compare sputum and 
blood differential cell percentages, serum ECP levels and 
PD,, FEV, metacholine between groups. The Spearman 
rank test was used to correlate markers of inflammation 
and bronchial hyperresponsiveness to methacholine or to 
HS inhalation (28). 
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TABLE 2. Inflammatory cell percentages in sputum induced by hypertonic saline inhalation in normal 
subjects and in subjects with occupational or non-occupational asthma (subjects with occupational 
asthma are divided according to the type of sensitizing agent; see Table 1) 
Occupational asthma 
Non-occupational 
LMWC HMWC asthma Normal 
Number of subjects 16 8 24 14 
Macrophages (%) 29 (1 l-86)* 39 (2-64)* 35 (13-75)* 70 (35-91) 
Lymphocytes (%) 0 (O-2 )* 0 (o-l)* 0 (o-2)* 4 (o-16) 
Neutrophils (%) 68 (12-87)*t 57 (30-87)* 46 (475)* 27 (2-62) 
Eosinophils (“!) 1 to-1WS 6 (2-22)* 13 (o-49)* 0 (O-l) 
*P<O.O5 vs. normal. 
tP<0.05 vs. non-occupational asthma. 
$P<O.O5 vs. HMWC asthma. 
0 0 
Normal NOA HMWC LMWC 
I 
FIG. 1. Induced sputum neutrophils (%) in normal sub- 
jects (Normal), non-occupational asthmatics (NOA), 
HMWC asthmatics and LMWC asthmatics. *Significantly 
different from all groups of asthmatic subjects. **P<O.O5. 
Results 
Although squamous cell contamination was relevant in 
some samples [median: 31% (l&86%)], all slides obtained 
from the examined subjects were considered satisfactory 
and used for differential cell counts, because a minimum of 
500 non-squamous cells were counted for every subject. 
Percentages of all inflammatory cells in HS-induced 
sputum were significantly different in asthmatic subjects 
compared with normal subjects (Table 2). Sputum 
neutrophil percentages were higher in asthmatic than in 
normal subjects (Fig. 1). This difference persisted even 
when only non-smokers were considered. Among asthmat- 
ics, subjects with asthma due to LMWCs had the highest 
sputum neutrophil percentages, and this difference reached 
statistical significance in the comparison with non- 
occupational asthmatics but not in the comparison with 
HMWC asthmatics. Sputum eosinophil percentages in sub- 
jects with occupational asthma due to LMWCs were sig- 
nificantly lower than in subjects with non-occupational 
asthma and in subjects with occupational asthma due to 
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FIG. 2. Induced sputum eosinophils (%) in normal sub- 
jects (Normal), non-occupational asthmatics (NOA), 
HMWC asthmatics and LMWC asthmatics. *Significantly 
different from all groups of asthmatic subjects. **P<O.O5. 
HMWCs (Fig. 2). Taking the highest sputum eosinophil 
percentages observed in normal subjects (i.e. 1%) as the 
cut-off value for normal eosinophil levels in induced 
sputum, eosinophil percentages in induced sputum were 
above normal in eight (100%) subjects exposed to HMWCs, 
in ten (63%) subjects exposed to LMWCs and in 22 (92%) 
subjects with non-occupational asthma. Sputum macro- 
phage and lymphocyte percentages were significantly lower 
in asthmatic than in normal subjects, with no difference 
among the three groups of asthmatics. Sputum total 
inflammatory cell counts were not different among the four 
groups. 
Blood eosinophil percentages in subjects with non- 
occupational asthma and in subjects with asthma due to 
HMWCs were significantly higher than in subjects with 
asthma due to LMWCs (Table 3). In particular, blood 
eosinophil percentages was greater than 5% (laboratory 
reference value) in one (12.5%) subject exposed to 
HMWCs, in one (6.2%) subject exposed to LMWC and in 
ten (41.6%) subjects with non-occupational asthma. Serum 
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TABLE 3. Functional findings of normal subjects and subjects with occupational and non-occupational asthma (subjects with 
occupational asthma are divided according to the type of sensitizing agent; see Table 1) 
Occupational asthma 
LMWC HMWC 
Non-occupational 
asthma Normal 
Number of subjects 16 8 24 14 
FEV, (% predicted), mean f SD 89.5 22 14.3 88.9 f 19.5 89.7 f 14.1 105.4 f 10.7 
PD,, FEV, (mg), median (range) 0.274 (0.053-0.705) 0.264 (0.1254.608) 0.153 (0.050-0.421) >3.2*? 
Blood eosinophils (%), median (range) 0.08 (0.3-5.1)* 2.9 (1.2-9.4) 5.4 (1.3-12.6) - 
Serum ECP, median (range) 3.9 (2.2-15.3) 7.1 (2.655.7) 6.8 (2-25) - 
PEF MA (%), median (range) 13 (433) 10 (3-26) 10 (O-19) - 
Days with MA >lO% (%) 69 43 48 - 
HS inhalation 
Duration of test (min), mean * SD 16.9 f 9.81 11.3 i 9.2 10.8 f 6.5 30&o* 
AFEV, (%) HS, mean f SD 19.6 h 9.21 29.6 k 15.9 31.4 f 9.7 7.0 zk 5.1* 
*P<O.O5 vs. other groups. 
tFor statistical analysis it is considered to be 3.2 mg (maximal delivered dose of methacholine). 
$P<O.O5 vs. non-occupational asthma. 
ECP levels were higher than normal in four asthmatic 
subjects only, and on average they were not different among 
the groups of subjects studied. 
Baseline FEV, and PD,, FEV, were lower in asthmatic 
than in normal subjects, but they were similar in the 
different groups of asthmatic subjects, as were indices of 
PEF variability. Bronchial response to HS inhalation, 
expressed either by maximum percentage FEV, fall from 
baseline value or as duration of HS inhalation, was greater 
in subjects with asthma due to HMWCs and in subjects 
with non-occupational asthma than in subjects with asthma 
due to LMWCs. Normal subjects showed small responses 
to HS inhalation (Table 3). 
A positive significant correlation between sputum and 
blood eosinophil percentages was observed when both all 
asthmatic subjects (Fig. 3) and single groups were con- 
sidered, except the HMWC group. A positive correlation 
was also observed in all asthmatic subjects between sputum 
eosinophil percentages and the response to HS inhalation, 
expressed as duration of HS inhalation @= - 0.4, P=O.O3) 
but not between sputum eosinophil percentages and PD,, 
FEV, metacholine @= - 0.09, PzO.9). 
Discussion 
Our study shows that symptomatic subjects with occupa- 
tional asthma, currently exposed to the sensitizing agent, 
have higher percentages of neutrophils and eosinophils in 
HS-induced sputum than normal subjects. To the best of 
our knowledge, this is the first report of induced sputum 
evaluation in subjects with occupational asthma, without 
an acute exacerbation of asthma and without specific 
bronchial challenge test. A previous study reported sputum 
cell composition in TDI asthmatic patients evaluated after 
bronchial challenge with diisocyanates (29). The compari- 
son with subjects with non-occupational asthma (mostly 
40 
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Serum eosinophils (%) 
FIG. 3. Correlation between blood and sputum eosinophil 
percentages in subjects with occupational asthma (0, 
LMWC; 0, HMWC) and non-occupational asthma (A). 
p=O.64; P=O.OOOl. 
atopics) but with asthma severity of similar degree, as 
assessed by symptoms, PEF variability and bronchial 
hyperresponsiveness to methacholine, showed that subjects 
with occupational asthma due to LMWCs had lower 
eosinophil percentages in sputum and in blood, and higher 
neutrophil percentages in sputum, than subjects with non- 
occupational asthma. This fact was not observed in subjects 
with occupational asthma due to HMWCs. 
Neutrophils seem to be common inhabitants of the 
large airways, and previous studies have shown increased 
percentages of neutrophils in BL in non-smoking 
normal subjects (30). Some studies had observed increased 
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percentages of neutrophils in BL from subjects with 
occupational or non-occupational asthma (l&31), but in 
most studies neutrophil percentages were in the normal 
range (3-5). On the other hand, subjects with occupational 
asthma showed increased neutrophil counts in BL some 
hours after acute exposure to TDI or plicatic acid dust in 
a challenge chamber (19,20). An increase in sputum 
neutrophils has also been reported in subjects with non- 
occupational asthma during acute exacerbation of asthma 
(32). In the present study, the difference in sputum 
neutrophil percentages between normal and asthmatic sub- 
jects was not ascribed to smoking habit, because it still 
persisted when ex-smokers were excluded. This observation 
points out that neutrophils may have a role in airway 
inflammation in asthma. This fact seems particularly 
relevant in asthma due to simple chemicals, where sputum 
neutrophil percentages were higher than in other asthmatic 
groups. It has in been hypothesized that LMWCs, like 
diisocyanates and plicatic acid, induce asthma by a non-IgE 
immunological mechanism, but they may also have other 
direct effects on the airways, like their environmental 
pollutants which induce significant oxidative damage on 
airway mucosa (33). Bronchial challenge with TDI induces 
a prominent neutrophilic acute airway inflammation as 
detected by BAL (19) and bronchial epithelial cells from 
animals exposed to TDI release some cytokines with poten- 
tial neutrophil chemotactic activity on neutrophils (34). 
Subjects with occupational asthma due to LMWCs were 
slightly older than the other asthmatic groups. However, 
there is no evidence that sputum neutrophilic inflammation 
increases with age. Our data on neutrophilic inflammation 
partly confirm previous results obtained by Boulet et al. in 
a group of subjects with occupational asthma due to either 
HMWCs or LMWCs, examined after recent cessation of 
exposure (18). In particular, subepithelial neutrophils were 
significantly increased in both asthmatic groups compared 
with normal subjects, although no difference was observed 
between HMWC and LMWC asthmatics. By contrast, BL 
analysis in the same subjects showed no difference in 
differential cell counts between normals and asthmatics. 
The discrepancy with the results of the present study, 
showing high eosinophil percentages in sputum of patients 
with HMWC asthma compared to patients with LMWC 
asthma, could be ascribed to the different technique used to 
evaluate airway inflammation (BL VS. sputum) or to the 
withdrawal of the occupational exposure in the subjects of 
the study by Boulet et al. (18). The discrepancy between 
induced sputum, BL and bronchial biopsies in the types of 
inflammatory cells can be explained by the different site of 
sampling (proximal vs. distal airways) and by the differ- 
ent activity of the inflammatory process (acute airway 
inflammation results in polymorphonuclear cells migrating 
in the airway lumen, chronic airway inflammation in 
mononuclear cell infiltration in the airway wall) (12). 
Although asthmatic subjects had higher sputum 
eosinophil percentages than normal subjects, subjects with 
asthma due to LMWCs had significantly lower sputum and 
blood eosinophil percentages than subjects with non- 
occupational asthma and subjects with asthma due to 
HMWCs. This fact was not related to a different severity 
of asthma, as symptoms, bronchial responsiveness to 
methacholine and PEF variability were not significantly 
different among asthmatic groups; airway response to HS 
inhalation only was smaller in subjects with asthma due to 
LMWCs. The different percentages of sputum, and blood 
eosinophils in occupational asthmatics may also be related 
to a different degree of exposure to the sensitizer in the 
workplace: it is well known that, in the furniture and 
shoe-making industries, the use of TDI varnish or MD1 
foam is usually intermittent, while exposure to flour, 
tobacco and wood dust is usually more continuous. Thus, 
clinical findings may be less sensitive than inflammatory cell 
counts in blood and in sputum in assessing different degrees 
of asthma severity. Finally, we cannot exclude the 
possibility that the higher eosinophil percentages in sputum 
of subjects with HMWC asthma may be due to a different 
pathogenetic mechanism of HMWC asthma with respect to 
LMWC asthma. 
Eight out of 24 occupational asthmatics had been 
previously treated with inhaled corticosteroids, which were 
with drawn 1 month at least before examination. In these 
subjects, stopping of regular medication could have induced 
an asthma exacerbation. However, when these subjects 
were excluded, the difference in the percentage of 
inflammatory cells in sputum and blood among groups was 
still present [e.g. sputum eosinophils: 1.5% (O-14%), 6.4% 
(2222%) and 12.7% (049%) in LMWC, HMWC and 
non-occupational asthmatics respectively]. 
The groups of asthmatic subjects were different for 
sputum and blood eosinophil counts but not for serum ECP 
levels. Also, most asthmatic subjects had sputum eosinophil 
percentages >l% (which is the highest value observed in 
normal subjects in our laboratory), while a small percentage 
of asthmatic subjects had blood eosinophil percentages and 
serum ECP levels higher than normal values, This confirms 
that induced sputum markers are more sensitive than blood 
or serum ECP markers in detecting the presence of airway 
inflammation. 
Finally, we have observed a positive correlation between 
sputum eosinophil percentages and bronchial hyper- 
responsiveness to HS but not to methacholine inhalation, 
probably because the response to HS detects better than 
methacholine asthmatics patients with a higher severity of 
airway inflammation. 
In conclusion, markers of airway inflammation can be 
observed in HS-induced sputum of subjects with occu- 
pational asthma currently exposed to the sensitizing agent. 
Although some difference in inflammatory cell percentages 
in subjects with different aetiologies of asthma were 
observed, depending on the severity of asthma and on the 
intermittent vs. continuous exposure to the sensitizer in 
the workplace, sputum eosinophil count was able to detect 
the presence of airway inflammation better that blood 
markers. 
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